Shanghai Titan Scientific Co., Ltd. (SHA:688133)
China · Delayed Price · Currency is CNY 23.28
+0.18 (0.78%)
May 19, 2026, 3:00 PM CST
Shanghai Titan Scientific Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,494 | 2,515 | 2,883 | 2,769 | 2,607 | 2,164 |
Other Revenue | - | - | 0.65 | 0.56 | 0.95 | 0.3 |
| 2,494 | 2,515 | 2,884 | 2,770 | 2,608 | 2,164 | |
Revenue Growth (YoY) | -11.67% | -12.79% | 4.11% | 6.20% | 20.50% | 56.32% |
Cost of Revenue | 2,571 | 2,562 | 2,317 | 2,193 | 2,044 | 1,706 |
Gross Profit | -76.77 | -47.21 | 566.07 | 576.24 | 563.42 | 457.8 |
Selling, General & Admin | 12.69 | - | 382.82 | 341.18 | 271.78 | 202.93 |
Research & Development | 1.5 | - | 133.99 | 136.16 | 114.17 | 81.81 |
Other Operating Expenses | -8.41 | - | 7.13 | 5.54 | 6.62 | 5.69 |
Operating Expenses | 5.77 | - | 531.91 | 494.3 | 408.79 | 301.47 |
Operating Income | -82.55 | -47.21 | 34.16 | 81.94 | 154.64 | 156.33 |
Interest Expense | - | - | -40.82 | -27.99 | -27 | -9.79 |
Interest & Investment Income | 0.21 | - | 10.61 | 13.98 | 10.43 | 8.83 |
Currency Exchange Gain (Loss) | - | - | -0.8 | -3.63 | -2.86 | 0.13 |
Other Non Operating Income (Expenses) | 19.45 | 22.39 | -3.37 | -3.7 | -2.7 | -3.26 |
EBT Excluding Unusual Items | -62.89 | -24.82 | -0.21 | 60.61 | 132.51 | 152.25 |
Gain (Loss) on Sale of Investments | 0.03 | - | 1.77 | 11.33 | - | 12.22 |
Gain (Loss) on Sale of Assets | 0.01 | - | 1.73 | 0.62 | - | -0.01 |
Asset Writedown | -0.35 | - | - | - | - | - |
Other Unusual Items | - | - | 3.64 | 12.63 | 18.59 | 5.25 |
Pretax Income | -63.2 | -24.82 | 6.93 | 85.19 | 151.09 | 169.72 |
Income Tax Expense | -12.33 | -11.77 | -0.83 | 9.88 | 19.38 | 27.43 |
Earnings From Continuing Operations | -50.87 | -13.04 | 7.76 | 75.31 | 131.72 | 142.29 |
Minority Interest in Earnings | 0.31 | - | 5.13 | -2.74 | -6.91 | 1.67 |
Net Income | -50.56 | -13.04 | 12.89 | 72.57 | 124.81 | 143.95 |
Net Income to Common | -50.56 | -13.04 | 12.89 | 72.57 | 124.81 | 143.95 |
Net Income Growth | - | - | -82.23% | -41.85% | -13.30% | 40.09% |
Shares Outstanding (Basic) | 161 | 163 | 161 | 164 | 155 | 149 |
Shares Outstanding (Diluted) | 161 | 163 | 161 | 164 | 155 | 149 |
Shares Change (YoY) | -1.69% | 1.18% | -1.64% | 5.83% | 3.72% | 26.00% |
EPS (Basic) | -0.31 | -0.08 | 0.08 | 0.44 | 0.81 | 0.96 |
EPS (Diluted) | -0.31 | -0.08 | 0.08 | 0.44 | 0.81 | 0.96 |
EPS Growth | - | - | -81.94% | -45.06% | -16.41% | 11.18% |
Free Cash Flow | - | - | -291.93 | -589.46 | -450.97 | -377.43 |
Free Cash Flow Per Share | - | - | -1.81 | -3.60 | -2.91 | -2.53 |
Dividend Per Share | - | - | 0.070 | 0.071 | 0.102 | 0.102 |
Dividend Growth | - | - | -1.96% | -30.00% | 0.20% | -51.34% |
Gross Margin | -3.08% | -1.88% | 19.63% | 20.81% | 21.61% | 21.15% |
Operating Margin | -3.31% | -1.88% | 1.19% | 2.96% | 5.93% | 7.22% |
Profit Margin | -2.03% | -0.52% | 0.45% | 2.62% | 4.79% | 6.65% |
Free Cash Flow Margin | - | - | -10.12% | -21.28% | -17.29% | -17.44% |
EBITDA | - | 6.74 | 88.12 | 122.27 | 181.94 | 172.22 |
EBITDA Margin | - | 0.27% | 3.06% | 4.41% | 6.98% | 7.96% |
D&A For EBITDA | - | 53.95 | 53.95 | 40.32 | 27.3 | 15.88 |
EBIT | -82.55 | -47.21 | 34.16 | 81.94 | 154.64 | 156.33 |
EBIT Margin | -3.31% | -1.88% | 1.19% | 2.96% | 5.93% | 7.22% |
Effective Tax Rate | - | - | - | 11.60% | 12.82% | 16.16% |
Revenue as Reported | - | - | 2,884 | 2,770 | 2,608 | 2,164 |
Advertising Expenses | - | - | 16.21 | 15.15 | 9.35 | 12.1 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.